By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelr8 said that it has signed a technology evaluation agreement with an unnamed global diagnostic company for its BACcel system.

Accelr8 said that the deal includes an option to license the system and develop diagnostic products based on the technology. The firm said that it will receive an initial payment plus additional payments based on completion of data evaluation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.